Navigation Links
PTC Therapeutics Announces Publication of Preclinical Data in PNAS
Date:2/4/2008

Data Show PTC124 Addresses Underlying Cause of Genetic Disorders and

Restores Protein Function in Cystic Fibrosis Model

SOUTH PLAINFIELD, N.J., Feb. 4 /PRNewswire/ -- PTC Therapeutics, Inc. today announced the publication of new preclinical data in the February 12, 2008 edition of the Proceedings of the National Academy of Sciences (PNAS) which show that PTC124, a novel drug designed to bypass nonsense mutations, was active in a preclinical model of cystic fibrosis (CF). These results support and add to research published last year in the journal Nature, which demonstrated the activity of PTC124 in a preclinical model of Duchenne muscular dystrophy (DMD). PTC124 has demonstrated pharmacodynamic proof of concept in Phase 2a clinical trials in nonsense-mutation-mediated CF and DMD.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )

PTC has catalogued over 2,400 distinct genetic disorders where nonsense mutations are the cause of the disease in a significant percentage of patients. Nonsense mutations inactivate gene function and are known to cause anywhere from five to 70 percent of the individual cases of most inherited diseases, such as cystic fibrosis (10%) and Hurler's syndrome (70%).

"The preclinical and clinical data on PTC124 support our hope that this drug will be an important disease-modifying therapy for cystic fibrosis," said Robert J. Beall, Ph.D., President and CEO of the Cystic Fibrosis Foundation. "This is an exciting potential new treatment for patients afflicted with nonsense-mutation-mediated CF. We look forward to the next stage of clinical development to demonstrate the benefits of this promising new investigational drug."

As with the DMD data published in Nature, the results published in PNAS further demonstrate that PTC124 targets genetic mutations in a completely new way. PTC124 functions by overcomi
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImaRx Therapeutics Transitions Business Strategy
2. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
3. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
4. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
5. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
6. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
7. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
8. Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
9. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
10. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
11. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... NEW YORK, Nov. 25 Reportlinker.co...vailable in its catalogue: ,, United States De... ,, http://www.reportlinker.com/p0158733/Unit...asts-to-2015.html ,, United States Dental Devi...ummary ,, This report is an essential source f...
(Date:11/25/2009)...CITY, Calif., Nov. 25 Ab...mpany manufacturing point-of-care blood analysis s...man and chief executive officer, will present at t...e on Wednesday, December 2, 2009 at 2:00 p.m. ET. ... Hotel in New York City. ,, About Abaxis ,...
(Date:11/25/2009)... WALTHAM, Mass., Nov. 25 According...thority on medical technology market intelligence,...on devices will continue to see rapid growth over ...owdown. MRG,s US Markets for Trauma Devices 201...y dynamic over the next five years, with competito...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Advanced Life Sciences Restanza 28TM 29 Shows 100 25 Survival In Confirmatory Anthrax Study 12741 1Advanced Life Sciences Restanza 28TM 29 Shows 100 25 Survival In Confirmatory Anthrax Study 12741 2Advanced Life Sciences Restanza 28TM 29 Shows 100 25 Survival In Confirmatory Anthrax Study 12741 3The New Dragon Medical 10 1 is Now Available 49740 1The New Dragon Medical 10 1 is Now Available 49740 2The New Dragon Medical 10 1 is Now Available 49740 3Johns Hopkins Center for Communication Programs Honors MTV Executive for Outstanding Contribution to Health Communication 49738 1Johns Hopkins Center for Communication Programs Honors MTV Executive for Outstanding Contribution to Health Communication 49738 2Johns Hopkins Center for Communication Programs Honors MTV Executive for Outstanding Contribution to Health Communication 49738 3
...ists Offer Tips on Preventing Possibly Life-Threat...., Sept. 25 The American,Physical Therapy Associa...y,Acting Surgeon General Steven K Galson, MD, MPH ...sis and pulmonary embolism in the United States., ...ofessor of physical,therapy at Regis University in...
...25 /PRNewswire-FirstCall/ - Fralex Therapeutics In...l technology company,developing a non-invasive neu...eceiving results of the interim analysis for the R...e use of Complex Neural Pulse or CNP(TM),therapy f...omyalgia., The Independent Data Monitoring Commit...
Other Medicine Technology:APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 3Fralex provides update on timing of interim analysis results 2
(Date:11/28/2009)... , CHICAGO, Nov. 28 Welco...PACS solution for the clinical routine from Siem... and Communications System (PACS) from Siemens w...lace, syngo .plaza is poised to change the wa...unveiling this innovation at the 95th Scientific...
(Date:11/28/2009)...dy finds gene variation believed to affect circadi...lthDay News) -- New research suggests that an inte...factor in the development of bipolar disorder in c...ation of the genetic makeup of 152 children with b... to major mood swings, and 140 children without th...
(Date:11/27/2009)... , KELOWNA, BC, Nov. 27 /PRNewswire/ - Upload...y seeing prime time in wellness. A combination of ... data upload are solving a long term concern over ...ble to accurately gauge and reward improved partic...hnologies is one of the first wellness suppliers t...
(Date:11/27/2009)... , SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCa...nnounced that Blair Lambert, CFO/COO, will present...ll be held at the May Fair Hotel in London, Englan...MT. ,, To listen to a live broadcast of The Gym..., please log on to www.gymboree.com, click on "Our...
(Date:11/27/2009)... , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswir...aq: SHMR ) ( "Shamir" ), a leading provider of in... lens market, announced today that its board of di... aggregate amount of US$ 10 million (approximately...representative rate of exchange), or approximately...
Breaking Medicine News(10 mins):Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3
...GARY, AB, --- September 28, 2007 - Oncolytics Biot...nced that an oral presentation covering interim re...N and radiation clinical trial for patients with a...m, U.K. The presentation, entitled Biological App...
...ironments got worse, symptoms worsened, too, study... family support and bad neighborhoods can aggravat...sts. , Edith Chen and colleagues at the University...al problems, such as crime and violence, in the ch...
...GTON, Sept. 28 "The actions of the,Connecticut Ca...d Judie,Brown, president of American Life League. ...raception in Catholic hospitals, but to claim that...rsonnel at Catholic hospitals to give the Plan B p...
...CRUZ, Calif., Sept. 28 ,Trichotillomania (compulsi...s -- including as many as 1 million children -- ye...ofessionals and the general public. The,Trichotill...om October 1-7, 2007., All Join Hands 2007 events...
...w designed to warn Americans about risks of indoor...ing an important step,which may help reduce signif... President Bush yesterday signed the Tanning Accou...the TAN,Act directs the U.S. Food and Drug Adminis...
...NVILLE, Fla., Sept. 28 Golden Corral,restaurants ... to,Jacksonville seniors, aged 65 and older. Six a...y and health care organizations, are offering,a ca...and clinical spokesperson for Jacksonville,s third...
Other Medicine News:Health News:Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials 2Health News:Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials 3Health News:Trouble at Home Boosts Kids' Asthma 2Health News:Connecticut Catholic Conference Wrong to Allow 'Plan B' in Catholic Hospitals 2Health News:National Trichotillomania Awareness Week Gives Help and Hope to Hair-Pullers 2Health News:American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act 2Health News:Golden Corral's Good Health Recipe for the Flu Season 2
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: